Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-Year results of a prospective, randomized, multicenter clinical trial

Journal of Urology

Volumn 171, Issue 6 I, 2004, Pages 2336-2340

  Hill, Brian ^a   Belville, William ^a   Bruskewitz, Reginald ^a   Issa, Muta ^a   Perez Marrero, Ramon ^a   Roehrborn, Claus ^a   Terris, Martha ^a   Naslund, Michael ^a  

^a NONE

Author keywords

Prostate; Prostatic hyperplasia; Transurethral resection of prostate; Urinary tract

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESIDUAL URINE; RETROGRADE EJACULATION; SCORING SYSTEM; STATISTICAL ANALYSIS; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA STRICTURE; URINARY TRACT OBSTRUCTION; URINE FLOW RATE; URINE INCONTINENCE;

EID: 2442614893     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000127761.87421.a0     Document Type: Article

References (20)

1. Chute, C. G., Panser, L. A., Girman, C. J., Oesterling, J. E., Guess, H. A., Jacobsen, S. J. et al: The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol, 150: 85, 1993
2. Anderson, J. T., Nickel, J. C., Marshall, V. R., Schulman, C. C. and Boyle, P.: Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia. Urology, 49: 839, 1997
3. Lukacs, B., Leplege, A., Thibault, P. and Jardin, A.: Prospective study of men with clinical benign prostate hyperplasia treated with alfuzosin by general practitioners: 1-year results. Urology, 48: 731, 1996
4. Lukacs, B., Grange, J. C., Comet, D. and McCarthy, C.: Three-year prospective study of 3228 clinical BPH patients treated with alfuzosin in General Practice. Prostate Cancer Prostatic Dis, 1: 276, 1998
5. McConnell, J. D., Roehrborn, C. G., Bautista, O. M., Andriole, G. L., Jr., Dixon, C. M., Kusek, J. W. et al: The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med, 349: 2387, 2003
6. De La Rosette, J. J. M. C. H., D'Ancona, F. C. H. and Debruyne, F. M. J.: Current status of thermotherapy of the prostate. J Urol, 157: 430, 1997
7. Muschter, R., de la Rosette, J. J., Whitfield, H., Pellerin, J. P., Madersbacher, S. and Gillatt, D.: Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia. Urology, 48: 223, 1996
8. Muschter, R., Schorsch, I., Danielli, L., Russel, C., Timoney, A., Yachia, D. et al: Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol, 164: 1565, 2000
9. Bruskewitz, R., Issa, M. M., Roehrborn, C. G., Naslund, M. J., Perez-Marrero, R., Shumaker, B. P. et al: A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol, 159: 1588, 1998
10. Roehrborn, C. G., Issa, M. M., Bruskewitz, R., Naslund, M. J., Oesterling, J. E., Perez-Marrero, R. et al: Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology, 51: 415, 1998
11. Schulman, C. C. and Zlotta, A. R.: Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience. Urology, 45: 28, 1995
12. Schulman, C. C., Zlotta, A. R., Rasor, J. S., Hourriez, L., Noel, J. C. and Edwards, S. D.: Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol, 24: 415, 1993
13. Rasor, J. S., Zlotta, A. R., Edwards, S. D. and Schulman, C. C.: Transurethral needle ablation (TUNA): thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol, 24: 411, 1993
14. Naslund, M. J.: Transurethral needle ablation of the prostate. Urology, 50: 167, 1997
15. Bruskewitz, R., Girman, C. J., Fowler, J., Rigby, O. F., Sullivan, M., Bracken, R. B., Fusilier, H. H. et al: Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study. Urology, 54: 670, 1999
16. Lepor, H.: Alpha blockade for the treatment of benign prostatic hyperplasia. Urol Clin North Am, 22: 375, 1995
17. Zlotta, A. R., Raviv, G., Peny, M.-O., Noel, J.-C., Haot, J. and Schulman, C. C.: Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study. J Urol, 157: 894, 1997
18. Minardi, D., Garofalo, F., Yehia, M., Baldassari, M., Muzzonigro, G. and Polito, M., Jr.: Transurethral needle ablation (TUNA) in benign prostatic hypertrophy: 2-year follow-up. Arch Ital Urol Androl, suppl., 70: 11, 1998
19. Steele, G. S. and Sleep, D. J.: Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup. J Urol, 158: 1834, 1997
20. Johannes, C. B., Araujo, A. B., Feldman, H. A., Derby, C. A., Kleinman, K. P. and McKinlay, J. B.: Incidence of erectile dysfunction in men 40 to 69 year old: longitudinal results from the Massachusetts male aging study. J Urol, 163: 460, 2000